New York, NY - September 24, 2024 - Sichenzia Ross Ference Carmel LLP announced that it has represented Elevai Labs, Inc. ("Elevai" or the "Company"), a pioneering force in medical aesthetics, in the …
Sichenzia Ross Ference Carmel LLP Represents Impact Biomedical Inc. in Closing of $4.5 Million Initial Public Offering
Press Release – New York, NY – September 18, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented Impact Biomedical Inc. (NYSE: IBO), a company discovering and developing new …
Sichenzia Ross Ference Carmel LLP Represents Tenon Medical Inc. in a $4.5 Million Public Offering Priced At-The-Market Under Nasdaq Rules
New York, NY - September 16, 2024 - Sichenzia Ross Ference Carmel LLP announced that it has represented Tenon Medical, Inc. ("Tenon" or the "Company"), a company transforming care for patients …
Sichenzia Ross Ference Carmel LLP Represents Vuzix Corporation in $20 million Private Placement Offering with Strategic Investor
Press Release – New York, NY – September 16, 2024 – Sichenzia Ross Ference Carmel LLP today announced that it represented Vuzix Corporation (NASDAQ: VUZI), a leading supplier of smart glasses and …
Sichenzia Ross Ference Carmel LLP represents BriaCell Therapeutics in $8.5 Million Offering
Press Release – New York, NY – September 12, 2024 – Sichenzia Ross Ference Carmel LLP announced today that it represented BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW) (TSX: BCT) , a …
Sichenzia Ross Ference Carmel LLP Represents NuZee, Inc. in Two PIPE Transactions Totaling $4.3 Million
Press Release – New York, NY – September 11, 2024 – Sichenzia Ross Ference Carmel LLP announced that it has represented NuZee, Inc. in two recent PIPE transactions, resulting in gross proceeds of …
